Makoto Sugawa
- Hematology top 10%
- Erythropoietin and Anemia Treatment 2
- Biotechnology top 10%
-
- Neurogenesis and neuroplasticity mechanisms 2
-
- Virus-based gene therapy research 4
-
- Nitric Oxide and Endothelin Effects 4
- Alzheimer's disease research and treatments 2
-
- Neuroscience and Neuropharmacology Research 4
- Axon Guidance and Neuronal Signaling 2
-
- CRISPR and Genetic Engineering 4
Makoto Sugawa
20 papers receiving 591 citations
Peers
Comparison fields: 5 of 80
- Hematology 117
- Biotechnology 76
- Developmental Neuroscience 27
- Neurology 48
- Genetics 47
Countries citing papers authored by Makoto Sugawa
This map shows the geographic impact of Makoto Sugawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Makoto Sugawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Makoto Sugawa more than expected).
Fields of papers citing papers by Makoto Sugawa
This network shows the impact of papers produced by Makoto Sugawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Makoto Sugawa. The network helps show where Makoto Sugawa may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Makoto Sugawa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 3 | |
| 2 | 2014 | 10 | |
| 3 | 2004 | 8 | |
| 4 | 2002 | 161 | |
| 5 | 2002 | 104 | |
| 6 | 2001 | 65 | |
| 7 | 2000 | 73 | |
| 8 | 1997 | 15 | |
| 9 | 1997 | 49 | |
| 10 | 1996 | 12 | |
| 11 | 1993 | 2 | |
| 12 | 1992 | 9 | |
| 13 | 1991 | 43 | |
| 14 | 1991 | 10 | |
| 15 | 1991 | 36 | |
| 16 | [Effects of BY-1949 on three kinds of experimental amnesia in rodents]. | 1990 | 1 |
| 17 | 1990 | 3 | |
| 18 | 1989 | 1 | |
| 19 | 1987 | 2 | |
| 20 | 1986 | 1 |
About Makoto Sugawa
Makoto Sugawa is a scholar working on Developmental Neuroscience, Cellular and Molecular Neuroscience and Neurology, having authored 20 papers that have together received 608 indexed citations. Recurring topics across this work include Virus-based gene therapy research (4 papers), Nitric Oxide and Endothelin Effects (4 papers), Neuroscience and Neuropharmacology Research (4 papers), CRISPR and Genetic Engineering (4 papers), Alzheimer's disease research and treatments (2 papers), Erythropoietin and Anemia Treatment (2 papers), Axon Guidance and Neuronal Signaling (2 papers) and Neurogenesis and neuroplasticity mechanisms (2 papers). The work is most often cited by research in Hematology (117 citations), Biotechnology (76 citations) and Developmental Neuroscience (27 citations). Makoto Sugawa has collaborated with scholars based in Japan, United States and Germany. Frequent co-authors include Hiroaki Asou, Hiroshi Suzuki, Yoko Sakurai, Noboru Higuchi, Jun‐ichi Miyazaki, Fumitake Gejyo, Junichiro James Kazama, Tohru Koide, Tohru Matsui and Takao Asano. Their work appears in journals such as Stroke, Brain Research and Journal of Cerebral Blood Flow & Metabolism.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.